Artificial Intelligence for Cardiovascular Care

Thomas M. Maddox, MD

Thomas M. Maddox, MD, MSc, Professor of Medicine, Cardiovascular Division at WashU Medicine, and colleagues recently published two articles outlining the current opportunities for AI to impact cardiovascular care. These articles highlight how AI is poised to affect almost every aspect of cardiovascular care. ” says Maddox. “Our group hopes that this work helps prepare […]

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

Thomas M. Maddox, MD

The document also strengthens advice regarding which medications should be started in all patients Thomas M. Maddox, MD, MSc, Professor of Medicine in the Cardiovascular Division at WashU Medicine, and colleagues recently published an Expert Consensus Decision Pathway (ECDP) for the many decisions required in the management and treatment of patients with heart failure with […]

McNerney and Jasim discuss the long-term endocrine effects of cancer treatment  (Links to an external site)

Kyle P. McNerney, MD of the Department of Pediatrics at Washington University School of Medicine and Sina Jasim, MD of the Division of Endocrinology, Metabolism and Lipid Research

On October 10, 2023, Kyle P. McNerney, MD of the Department of Pediatrics at Washington University School of Medicine and Sina Jasim, MD of the Division of Endocrinology, Metabolism and Lipid Research, had their book chapter titled “Long-Term Effects of Cancer Treatment” published in Familial Endocrine Cancer Syndromes: Navigating the Transition of Care for Pediatric and Adolescent Patients.  

Some sarcoma patients improve with T cell immunotherapy (Links to an external site)

According to a study led by Washington University School of Medicine in St. Louis, a new T cell immunotherapy — in which the patients’ own T cells are genetically modified to attack and kill cancer cells — is effective in treating some patients with two types of sarcoma, rare cancers of the body’s soft tissues. Shown is a cross section of a synovial sarcoma tumor.

Strategy effective against some rare, aggressive sarcomas with no other treatment options A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy — in which the patients’ own T cells are genetically modified to attack and kill cancer cells — is effective in […]

Civitelli Lab Published in JCI Insight (Links to an external site)

Roberto Civitelli, MD

In a recent publication in JCI Insight, researchers from the Civitelli Lab unveil the pivotal role of connexin43 within mesenchymal lineage cells, shedding light on its influence in regulating body adiposity and energy metabolism in mice.

Scheller Lab and Colleagues Published in JCI Insight (Links to an external site)

Erica Scheller, DDS, PhD

Members of the Scheller Lab in collaboration with the Milbrandt and DiAntonio groups at WashU published a paper in JCI Insight in which they found that loss of Sarm1 could completely protect female mice against the development of bone loss and severe osteoblast suppression secondary to type 1 diabetes. 

Powers Carson and Arora discuss negative correlations between BMI and glycated albumin  (Links to an external site)

Jennifer Powers Carson, PhD

In October of 2023, Jennifer Powers Carson, PhD and colleague, Jyoti Arora, MS of the Washington University School of Medicine, Center for Biostatistics and Data Science, had their work published by Clinical Biochemistry. The article was titled, “Glycated serum proteins and albumin but not glycated albumin show negative correlation with BMI in an overweight/obese, diabetic population from the United States.” 

In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms

Stephen T. Oh, MD, PhD

Study in Blood dissecting the role of NFκB signaling effectors in MPN disease biology Stephen T. Oh, MD, PhD, Co-Chief and Associate Professor of Medicine, Division of Hematology, Department of Medicine, Washington University School of Medicine in St. Louis, and has been published in Blood. The WashU group of researchers previously identified hyperactivation of NFκB […]

AI may predict spread of lung cancer to brain (Links to an external site)

lung image

Method may inform personalized cancer treatments Physicians treating patients with early-stage lung cancer face a conundrum: choosing potentially helpful yet toxic therapies such as chemotherapy, radiation or immunotherapy to knock out the cancer and lessen the risk of it spreading to the brain, or waiting to see if lung surgery alone proves sufficient. When up […]

Dr. David DeNardo Explores How the Tumor Microenvironment Affects Immune Responses to Cancer (Links to an external site)

David DeNardo, P.D

David DeNardo, Ph.D., is a Professor of Medicine and Co-Director of the Tumor Immunology Program at the Washington University St. Louis, School of Medicine.  His research team is working to understand why responses to cancer immunotherapy vary among patients. In studying and uncovering mechanisms of cancer immunology, Dr. DeNardo aims to identify strategies that can […]

Brain tumors: Fighting with targeted tools (Links to an external site)

Neurosurgeon Albert Kim, MD, PhD (center), and chief resident Adam Bevan, MD, PhD, perform a right parietal craniotomy to remove a brain tumor.

Whether malignant or benign, a brain tumor is life-altering. Malignant tumors can spread and become deadly. And benign doesn’t mean harmless; benign tumors can cause serious problems such as paralysis, seizures and personality changes depending on which parts of the brain they affect.

Washington University joins NIH cancer screening clinical trials network (Links to an external site)

Washington University School of Medicine in St. Louis is one of seven U.S. institutions joining a new national clinical trials network launched by the National Cancer Institute (NCI) to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths. A key priority of the network is to ensure the clinical trials include participants from diverse populations. (Image: Getty Images)

New network to evaluate emerging technologies in diverse populations Washington University School of Medicine in St. Louis is joining a new clinical trials network launched by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths. […]

WashU Kidney O’Brien Center Takes CKD Research to the Next Level through Team Science (Links to an external site)

Washington University Kidney O’Brien Center for Chronic Kidney Disease Research

Chronic kidney disease (CKD) is a highly under-recognized disease that affects almost 15% of the US population and carries significant morbidity and mortality.  Although important scientific advances promise to accelerate CKD research, many are not accessible to the kidney research community due to limited expertise and/or the need for expensive equipment.

Radiation therapy may be potential heart failure treatment (Links to an external site)

Radiotherapy may improve heart function by reducing inflammatory immune cells Cardiologists and radiation oncologists at Washington University School of Medicine in St. Louis pioneered the use of radiation therapy — a strategy typically used against cancer — to treat patients with a life-threatening abnormal heart rhythm called ventricular tachycardia.

Researchers identify way to block alphavirus infection (Links to an external site)

Researchers at Washington University School of Medicine in St. Louis have found an innovative way to block infection by a variety of alphaviruses, a group of mosquito-borne viruses that can cause joint and brain infections in people. The study, led by Michael S. Diamond, MD, PhD, the Herbert S. Gasser Professor of Medicine, and Daved […]

Ying Maggie Chen Lab and Collaborators Uncover Biotherapeutic Properties of MANF Protein (Links to an external site)

Ying (Maggie) Chen, MD, PhD

In their newly-published article in Nature Communications, a multi-center group led by Ying Maggie Chen, MD, PhD, WashU Division of Nephrology, describes previously unknown mechanisms of action of mesencephalic astrocyte-derived neurotrophic factor (MANF) and its therapeutic function, with regards to kidney disease.  MANF is a secreted endoplasmic reticulum (ER) protein that possesses cytoprotective properties.

Epigenome’s role in cancer revealed in new study (Links to an external site)

Scientists at Washington University School of Medicine in St. Louis have analyzed the epigenomes of tumor cells across 11 cancer types and revealed important roles for this regulatory system of the genome in the way cancer forms, grows and spreads. (Image: Getty Images)

Epigenetics of cancer critical in understanding tumor initiation, growth and spreading For decades, scientists have been sequencing the DNA of many cancer types, identifying errors in the genetic code to help understand the formation of tumors, how they grow and what leads to their spreading. But sometimes cancer is driven by subtle changes in the […]

Siteman Investment Program awards $2 million in cancer research grants (Links to an external site)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is pleased to announce funding for eight new projects, including research projects focused on prostate cancer, lymphoma, and breast cancer, as well as a team science project with a focus on myeloproliferative neoplasms, a blood malignancy that can develop into acute myeloid leukemia. Also included are two […]

Scientists reveal how proteins drive growth of multiple cancer types (Links to an external site)

Understanding of molecular basis of cancer may lead to new therapies Scientists have completed a deep analysis of the proteins driving cancer across multiple tumor types, information that can’t be assessed by genome sequencing alone. Understanding how proteins operate in cancer cells raises the prospect of new therapies that block key proteins that drive cancer […]

Kidney tissue atlas serves as blueprint for understanding kidney injury, disease (Links to an external site)

Research collaboration details molecular knowledge, step toward personalized medicine Scientists at Washington University School of Medicine in St. Louis are among the leaders of a multi-institution research team that has built an atlas focused on the kidney’s myriad cells. The aim of the kidney tissue atlas is to further the understanding of kidney injury and disease.

Anti-inflammatory drugs did not speed COVID-19 recovery but prevented deaths (Links to an external site)

Study could expand treatment options for patients with severe COVID-19 Two drugs commonly used to treat inflammatory diseases such as rheumatoid arthritis and psoriasis did not shorten recovery time for patients hospitalized with severe COVID-19 but did reduce the likelihood of death when compared with standard care alone, according to a national study led by […]

In battling obesity and prediabetes, combining exercise with weight loss is key (Links to an external site)

Insulin sensitivity improved twofold when exercise paired with 10% weight loss Researchers at Washington University School of Medicine in St. Louis have found that combining regular exercise with a 10% loss of body weight more than doubles sensitivity to insulin, compared with a 10% weight loss without exercise. Enhanced sensitivity to insulin has important health […]

Kidney donor updates for those with HCV and COVID-19

The association of donor hepatitis C virus infection with 3-year kidney transplant outcomes in the era of direct-acting antiviral medications Tarek Alhamad, MD, MS, MBA, Associate Professor of Medicine, Medical Director of Transplant Nephrology, Division of Nephrology, recently had two manuscripts published in JAMA Open and the American Journal of Transplantation regarding new findings of […]

Scanning electron microscopy of human islet cilia (Links to an external site)

Primary cilia are vital cell-surface sensory organelles, but their physical dimensions have eluded characterization due to difficulty in isolating and studying these enigmatic structures, especially in human tissues. In the present study, we use a multi-scale surface scanning approach to enable a 3D architectural study of human primary cilia, the first in pancreatic islets and […]

Dr. Fumihiko Urano featured in PBS Wolfram syndrome documentary  (Links to an external site)

Dr. Fumihiko Urano

In April, Fumihiko Urano, MD, PhD was featured in the documentary “Colorado Voices: Ellie White,” to raise awareness of the rare genetic disorder, Wolfram syndrome. The short documentary was published by Rocky Mountain PBS and tells the story of Colorado college student Ellie White, who lives with the disorder. Although the disorder is very rare […]

Red flags indicate risk for early-onset colorectal cancer (Links to an external site)

Researchers at Washington University School of Medicine in St. Louis have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer. These red flags may be key to earlier detection and diagnosis of early-onset colorectal cancer among younger adults. The number of young adults with colorectal cancer has nearly doubled […]

Kulkarni Lab investigates modulating host immune response in the lungs in severe pneumonia

Hrishikesh Kulkarni MD, MSCI, from the Division of Pulmonary and Critical Care Medicine recently had two manuscripts published in Science Immunology and a Phase 3 clinical Trial on complement inhibition in COVID-19 in the Lancet Respiratory Medicine. Lung epithelial cell–derived C3 protects against pneumonia-induced lung injury The complement cascade is made up of innate immune defense proteins that protect […]

Grant supports training physician-scientists in cancer research (Links to an external site)

Researchers at Washington University School of Medicine in St. Louis have received a grant from the National Institutes of Health (NIH) to support training and mentorship for early-career physician-scientists. This relatively new funding opportunity — called Stimulating Access to Research During Residency (StARR) — will provide support for early-career physicians pursuing careers in cancer research.

Noninvasive electromyometrial imaging (EMMI) of human uterine maturation during term labor

Noninvasive electromyometrial imaging of human uterine maturations during term labor

EMMI helps assess uterine contractions to aid in preventing preterm deliveries Dr. Phillip Cuculich, Cardiovascular Division at Washington University School of Medicine in St. Louis, shared new findings that were published in Nature Communication. The group of doctors led by Dr. Yong Wang, published the “first-in-woman” study blending the disciplines of cardiac electrophysiology and obstetrics. […]

Southern Society for Clinical Investigation (SSCI) – Important Upcoming Deadlines

SSCI Research Scholar Award Deadline – September 1Details and information on this $25,000 (plus 10% indirect costs) pilot funding award can be found at here. SRM 2023 Abstract Deadline – October 7Information on SRM 2023 and abstract submission will soon be available on our website. Abstract submission site will open August 1. SSCI Mentor of […]